Founded in Chicago, Briteseed is a pioneering surgical technology company dedicated to enhancing operating room efficiency through next-generation smart surgical tools. The company's core mission is to improve the safety and outcomes of surgical procedures by integrating hyperspectral imaging technology into laparoscopic and robotic surgical instruments. Briteseed's product suite includes advanced energy devices, staplers, and dissection tools that provide real-time sensing of critical structures, seamlessly fitting into existing surgical workflows and displaying actionable information on standard O.R. monitors.

Notable figures associated with Briteseed include CEO Jonathan Gunn, JD, PhD, who leads the company's innovative efforts. Briteseed has attracted significant attention from investors and the medical community for its groundbreaking technology. Key achievements include the successful development and integration of their Smart Vision Engine, which offers unparalleled precision and power in real-time visualization during surgeries. Overall, Briteseed's impact lies in its potential to revolutionize surgical practices, making procedures safer and more efficient for both surgeons and patients.